Malaria death toll disputed
Nature News , 03022012 doi: 10.1038/nature.2012.9974
Zoe Cormier
Study doubles official estimate, but scientists say its methods are flawed.
Minnesota starts to destroy stored blood spots
Nature News , 03022012 doi: 10.1038/nature.2012.9971
Meredith Wadman
Court ruling that the state must get consent to store samples from newborn screening could hinder biomedical research.
Isotopes hint at North Korean nuclear test
Nature News , 03022012 doi: 10.1038/nature.2012.9972
Geoff Brumfiel
Data suggest that the country has experimented with a fusion boost to its fission weapons.
Europe's research plan starts to take shape
Nature News , 03022012 doi: 10.1038/nature.2012.9973
Lucas Laursen
Teresa Riera Madurell describes her goals for the Horizon 2020 funding programme.
Researchers feel pressure to cite superfluous papers
Nature News , 02022012 doi: 10.1038/nature.2012.9968
Richard Van Noorden
First survey to quantify problem finds that junior faculty are more likely to be targeted.
One genome from many
Nature News , 02022012 doi: 10.1038/nature.2012.9969
Virginia Gewin
Researchers extract genome for single organism from water sample.
Questions hang over red-wine chemical
Nature News , 02022012 doi: 10.1038/nature.2012.9970
Ewen Callaway
How resveratrol benefits health a matter of debate.
Norway to bring cancer-gene tests to the clinic
Nature News , 02022012 doi: 10.1038/nature.2012.9949
Ewen Callaway
A pilot programme will use latest tumour-sequencing techniques to help guide cancer care.
Success through cooperation
Nature News , 01022012 doi: 10.1038/nature.2012.9924
Heidi Ledford
Anders Ekblom, head of science and integration at AstraZeneca, explains that the future of drug discovery lies in 'predictive innovation'.
African land grabs hinder sustainable development
Nature News , 01022012 doi: 10.1038/nature.2012.9955
Anjali Nayar
Sales of forest land to corporations are dispossessing inhabitants and harming ecosystems.
Seven days: 27 January–2 February 2012
Nature 482, 10 01022012 doi: 10.1038/482010a
The week in science: sequencing stock rebounds after takeover bid for Illumina; drug companies and nations team up against neglected diseases; and turmoil at the Global Fund.
Genomics ace quits Japan
Nature 482, 18 01022012 doi: 10.1038/482018a
David Cyranoski
Yusuke Nakamura blames government inertia for his move to the United States.
Japan plans to merge major science bodies
Nature 482, 19 01022012 doi: 10.1038/482019a
Ichiko Fuyuno
Drive to save money could increase bureaucracy.
Vaccine development: Man vs MRSA
Nature 482, 23 01022012 doi: 10.1038/482023a
Maryn McKenna
For decades, Robert Daum has studied the havoc wreaked by methicillin-resistant Staphylococcus aureus . Now he thinks he can stop it for good.
Marine ecology: Attack of the blobs
Nature 482, 20 01022012 doi: 10.1038/482020a
Mark Schrope
Jellyfish will bloom as ocean health declines, warn biologists. Are they already taking over?
Global health hits crisis point
Nature 482, 7 01022012 doi: 10.1038/482007a
Laurie Garrett
The Global Fund's drive to ensure sustainability and efficiency means that it may not be able to meet its commitments to combat disease, says Laurie Garrett.
A whiff of interstellar cloud
Nature News , 01022012 doi: 10.1038/nature.2012.9948
Eric Hand
NASA satellite sniffs 'alien' atoms from beyond the Solar System.
Spiders dodge cannibalism through remote copulation
Nature News , 01022012 doi: 10.1038/nature.2012.9939
Ed Yong
In some species, self-emasculation improves a male's chances of fatherhood.
Roche takeover bid poses challenge to Illumina
Nature News , 31012012 doi: 10.1038/nature.2012.9928
Erika Check Hayden
A merger could stifle innovation, say observers.
Voicegrams transform brain activity into words
Nature News , 31012012 doi: 10.1038/nature.2012.9945
Mo Costandi
Computational models decode and reconstruct neural responses to speech.